“Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s89. doi:10.25251/skin.4.supp.89.